每年專案
機構檔案
機構簡介
病理學科成立於民國五十年八月,是北醫創立甚早、歷史悠久的學科,由本校胡水旺與徐千田創辦人禮聘當時甫自美國哥倫比亞大學學成歸國,時任臺大醫學院副教授之病理界權威陳定堯教授擔任首任主任,並於五十一年八月開始醫學系及牙醫學系的病理學與病理實驗授課,而後陸續開設藥學系、醫技、護理等科系的病理教學。在北醫蓽路藍縷的年代,從零做起,默默耕耘建立北醫病理在教學與醫療服務的美名。陳教授於民國七十六年退休後,由黃德修教授接任學科主任,承繼優良傳統,嘉惠學子。而後繼任的歷任學科主任,皆積極延攬學有專精之優秀人才,秉持以學生為主體,教學為首要目標的使命。
病理學科除學校教學、研究及服務任務外,也負責北醫大三家附屬醫院(附設醫院、萬芳醫院及雙和醫院)所有組織與細胞病理檢查、各項臨床病理討論會、解剖病理專科醫師訓練及實習醫師、實習醫檢生病理實習,實現本校邁向國際一流醫學大學的願景。
指紋
過去五年中的合作和熱門研究領域
概要
-
陳 志榮
- 病理學科 - 教授
- 臨床醫學研究所 - 合聘教授
- 國際醫學研究碩博士學位學程 - 合聘教授
- 醫學院人工智慧醫療碩士在職專班 - 合聘教授
- 癌症生物學與藥物研發博士學位學程 - 合聘教授
- 臺北醫學大學附設醫院 - 主治醫師
- 臺北醫學大學癌症轉譯研究中心 - 成員
- 臺北醫學大學人工智慧醫療研究中心 - 成員
人員: Researcher
-
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer
Wen, Y-C., Tram, V. T. N., Chen, W-H., Li, C-H., Yeh, H. L., Thuy Dung, P. V., Jiang, K-C., Li, H-R., Huang, J., Hsiao, M., Chen, W-Y. & Liu, Y-N., 5月 4 2023, 於: Cell death & disease. 14, 5, p. 304研究成果: 雜誌貢獻 › 文章 › 同行評審
3 引文 斯高帕斯(Scopus) -
Cinnamic aldehyde, an anti-inflammatory component in Du-Huo-Ji-Sheng-Tang, ameliorates arthritis in II collagenase and monosodium iodoacetate induced osteoarthritis rat models
Tseng, S. H., Lee, C. J., Chen, S. H., Chen, C. H., Tsai, P. W., Hsieh, M. S., Chu, J. S. & Wang, C. C., 1月 2023, 於: Journal of Traditional and Complementary Medicine. 13, 1, p. 51-61 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma: Journal of Personalized Medicine
Huang, J-H., Chen, S-H., Liao, Y-M., Kao, Y-C., Ho, W-L., Chang, H., Tsai, M-L., Lee, H-L., Kuo, C-C., Tseng, S-H., Chang, C-Y., Hsieh, K. L., Lu, L-S., Chen, Y-J., Chiou, J-F., Hsieh, T-H., Liu, Y-R., Hsu, W., Li, W-T., Wu, Y-C., 及其他8 , 4月 2023研究成果: 其他貢獻
開啟存取
資料集
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H. (Contributor), Yin, J. J. (Creator), Lee, Y. (Creator), Chen, W. (Creator) & Liu, Y. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
資料集: Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
資料集: Dataset
-
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K. (Contributor), Huang, W. (Contributor), Bamodu, O. A. (Contributor), Lee, W. (Contributor), Wang, C. (Creator), Hsiao, M. (Contributor), Wang, L. (Creator) & Yeh, C. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4194263.v1, https://figshare.com/collections/Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/4194263/1
資料集: Dataset